Biosphere, an Oakland, CA-based startup creating superior bioproduction programs, raised $8.8M in Seed funding.
The spherical was led by Lowercarbon Capital and VXI Capital, with participation from Founders Fund, GS Futures, Caffeinated Capital, and B37 Ventures.
The corporate intends to make use of the funds to speed up its engineering and scale-up efforts, enabling fast deployment of their reactors at scale.
Led by CEO Brian Heligman, Biosphere is advancing a proprietary UV sterilization strategy that paves the best way for a brand new technology of bioreactors which are cheaper, and high-performing. This advance will cut back the dangers related to new product launches and drive down manufacturing prices, enabling extra accessible and scalable biotechnology options.
The corporate has additionally secured a $1.5M contract with the U.S. Division of Protection to use its know-how towards the environment friendly manufacturing of crucial bioproducts.
FinSMEs
09/01/2025
